Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Science Advances|May 26, 2023
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancerBar Kaufman, Orli Abramov, Anna Ievko, et al.Journal of Experimental & Clinical Cancer Research : CR|November 20, 2024
Dual inhibition of HERs and PD-1 counteract resistance in KRAS<sup>G12C</sup>-mutant head and neck cancerOfra Novoplansky, Sankar Jagadeeshan, Manu Prasad, et al.International Journal of Cancer|May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cellsMor Varon, Tal Levy, Gal Mazor, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination RepairXin Peng, Shaolu Zhang, Yingying Wang, et al.Cancers|June 2, 2021
IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck CancerMai Badarni, Manu Prasad, Artemiy Golden, et al.Signal Transduction and Targeted Therapy|February 16, 2026
PKC-eta promotes breast cancer metastasis by regulating the Hippo-YAP signaling pathwayVijayasteltar B Liju, Kamran Waidha, Amitha Muraleedharan, et al.Molecular Cancer|March 15, 2024
A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activationXin Peng, Xin Huang, Talal Ben Lulu, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2021
Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCsDivya Ram Jayaram, Sigal Frost, Chanan Argov, et al.Blood Advances|July 24, 2025
HLA-E[pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple MyelomaMuhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, et al.Science Translational Medicine|July 1, 2016
P-selectin is a nanotherapeutic delivery target in the tumor microenvironmentYosi Shamay, Moshe Elkabets, Hongyan Li, et al.Pageof 9